← Leaderboards
Carmen Molina-Paris
Triad National Security, Llc
$2,245,998
Attributed
$2,245,998
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $455.7K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,245,998 · 1
By mechanism
R01$2,245,998 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Infection”
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$207,651,224
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
Research focus
InfectionInfluenza A VirusBiobankGenotypeArthropodsCrimean-Congo Hemorrhagic Fever VirusCrimean Hemorrhagic FeverData CollectionData SetAffectCellsEnsureEpidemicEpidemiologyEvolutionFamilyFrequenciesGene ExpressionGenesGenetic EnhancementGenetic RecombinationBunyaviridaeEcologyIn Vitro
Grant awards (5)
US-UK Collab: Modelling reassortment at the cellular, clinical, and phylogenetic level in emerging Bunyaviruses$447,570
R01 · FY2025 · AI · contact PI
US-UK Collab: Modelling reassortment at the cellular, clinical, and phylogenetic level in emerging Bunyaviruses$447,570
R01 · FY2024 · AI · contact PI
US-UK Collab: Modelling reassortment at the cellular, clinical, and phylogenetic level in emerging Bunyaviruses$447,570
R01 · FY2023 · AI · contact PI
US-UK Collab: Modelling reassortment at the cellular, clinical, and phylogenetic level in emerging Bunyaviruses$447,570
R01 · FY2022 · AI · contact PI
US-UK Collab: Modelling reassortment at the cellular, clinical, and phylogenetic level in emerging Bunyaviruses$455,718
R01 · FY2021 · AI · contact PI